Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$29,802,704
-$1,306,006 QoQ
Shares Held
320,287
-8.5% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 282 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $3,286,710,193 across 292 Biotechnology names. BNTX ranks #13 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,870,015 | $928,892,550 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
759,971 | $473,872,316 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
924,561 | $278,320,596 | |
| 4 | RPRX |
Royalty Pharma plc
|
3,800,504 | $213,094,258 | |
| 5 | INCY |
Incyte Corp
|
1,605,980 | $182,053,892 | |
| 6 | ARGX |
Argenx SE
|
177,164 | $164,367,443 | |
| 7 | INSM |
INSMED Inc
|
826,431 | $88,114,072 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
381,366 | $71,422,223 |
All Filings in BNTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,802,704 | 320,287 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,108,710 | 350,008 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $30,569,766 | 321,111 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $30,728,314 | 311,583 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $33,617,688 | 315,748 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $23,080,066 | 253,460 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $28,202,738 | 247,501 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $25,187,197 | 212,067 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $16,307,533 | 202,931 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $15,698,365 | 170,172 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $16,678,063 | 158,026 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $14,758,091 | 135,844 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $13,864,039 | 128,454 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $12,673,253 | 101,736 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $14,195,939 | 94,501 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $12,315,353 | 91,306 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,577,615 | 77,650 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $10,193,518 | 59,765 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,061,921 | 31,272 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,235,053 | 26,503 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,067,899 | 18,170 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $4,746,598 | 43,471 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,581,010 | 43,928 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||